Gemcitabine Plus Flavopiridol in Treating Patients With Advanced Solid Tumors
Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
Phase I trial to study the effectiveness of gemcitabine plus flavopiridol in treating
patients who have advanced solid tumors. Drugs used in chemotherapy use different ways to
stop tumor cells from dividing so they stop growing or die. Combining more than one drug may
kill more tumor cells.